Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Baijin Life Science Holdings's annualized net income for the quarter that ended in Sep. 2025 was $0.56 Mil. Baijin Life Science Holdings's average shareholder tangible equity for the quarter that ended in Sep. 2025 was $13.65 Mil. Therefore, Baijin Life Science Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2025 was 4.09%.
The historical rank and industry rank for Baijin Life Science Holdings's Return-on-Tangible-Equity or its related term are showing as below:
MNNGF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -199.09 Med: -16.12 Max: 15.2
Current: -30.09
During the past 13 years, Baijin Life Science Holdings's highest Return-on-Tangible-Equity was 15.20%. The lowest was -199.09%. And the median was -16.12%.
MNNGF's Return-on-Tangible-Equity is ranked worse than 92.33% of 1056
companies
in the Retail - Cyclical industry
Industry Median: 8.275
vs MNNGF: -30.09
Baijin Life Science Holdings (OTCPK:MNNGF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Baijin Life Science Holdings Return-on-Tangible-Equity Related Terms
Baijin Life Science Holdings Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings Return-on-Tangible-Equity Chart
MNNGF vs TPR: Return-on-Tangible-Equity Comparison
For the Luxury Goods subindustry, Baijin Life Science Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Return-on-Tangible-Equity vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Sep. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.09% mean?
Baijin Life Science Holdings (MNNGF) has a Return-on-Tangible-Equity of 4.09% as of Sep. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Baijin Life Science Holdings and its competitors. According to the industry distribution chart, Baijin Life Science Holdings ranks #975 out of 1056 companies in the Retail - Cyclical industry, placing it in the top 92.3%.
Is Baijin Life Science Holdings' Return-on-Tangible-Equity too high?
Baijin Life Science Holdings' current Return-on-Tangible-Equity is 4.09%. The Retail - Cyclical industry median Return-on-Tangible-Equity is 8.28. Baijin Life Science Holdings' value of 4.09% is 50.6% below this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #975 out of 1056 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Return-on-Tangible-Equity compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #975 out of 1056 companies for Return-on-Tangible-Equity. This places Baijin Life Science Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.28. Baijin Life Science Holdings' value of 4.09% is 50.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Retail - Cyclical company?
The median Return-on-Tangible-Equity among Retail - Cyclical companies is 8.28, based on 1,056 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Return-on-Tangible-Equity of 4.09% is 50.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Return-on-Tangible-Equity is 8.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Return-on-Tangible-Equity is 4.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Return-on-Tangible-Equity of 4.09%. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 25% above its estimated fair value. The current Return-on-Tangible-Equity is 4.09% and 50.6% below the Retail - Cyclical industry median of 8.28. Baijin Life Science Holdings' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Return-on-Tangible-Equity is 4.09% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 25% above its estimated GF Value™ of $0.06.
Key valuation signals for MNNGF:
Return-on-Tangible-Equity: 4.09%
GF Value™: $0.06 vs. price of $0.08 (25% above fair value)
Industry Position: 50.6% below the Retail - Cyclical median (#975 of 1056)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
26GF Score
Get the complete analysis for MNNGF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
